
Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on June 25, 2025
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
8,352 cr
Turnover Ratio
16.09%
Expense Ratio
0.89%
Exit Load
1.00%
if redeemed within
Returns
- 1M: 2.17%
- 1Y: 16.08%
- 3M: 4.75%
- 3Y: 26.24%
- 6M: 0.11%
- 5Y: 22.75%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
483.201 | 19.09% | 3,689 cr | 0.9% | - |
Other plans of Nippon India Pharma